Table 3 Univariate analysis of postoperative biliary stone recurrence
Characteristics | Recurrence (n = 31) | No-recurrence (n = 151) | χ2 | P |
|---|---|---|---|---|
Gender [n(%)] | ||||
Male | 17 (54.8) | 87 (57.6) | ||
Female | 14 (45.2) | 64 (42.4) | 0.081 | 0.776 |
Age [n(%)] | ||||
≥ 65 | 19 (61.3) | 66 (43.7) | ||
< 65 | 12 (38.7) | 85 (56.3) | 3.194 | 0.074 |
Preoperative Tbil [umol/L,n(%)] | ||||
≥ 43 | 20 (64.5) | 70 (46.4) | ||
< 43 | 11 (35.5) | 81 (53.6) | 3.393 | 0.065 |
BMI | ||||
≥ 24 | 27 (87.1) | 85 (56.3) | ||
< 24 | 4 (12.9) | 66 (43.7) | 10.312 | 0.001 |
ALB [g/L,n(%)] | ||||
≥ 33 | 18 (58.1) | 94 (62.3) | ||
< 33 | 13 (41.9) | 57 (37.7) | 0.191 | 0.662 |
Hypertension [n(%)] | ||||
Positive | 9 (29.0) | 28 (18.5) | ||
Negative | 22 (71.0) | 123 (81.5) | 1.747 | 0.186 |
Coronary heart disease [n(%)] | ||||
Positive | 5 (16.1) | 19 (12.6) | ||
Negative | 26 (83.9) | 132 (87.4) | 0.058 | 0.81 |
Type 2 diabetes [n(%)] | ||||
Positive | 2 (6.5) | 19 (12.6) | ||
Negative | 29 (93.5) | 132 (87.4) | 0.442 | 0.506 |
Cerebral infarction [n(%)] | ||||
Positive | 14 (45.2) | 35 (23.2) | ||
Negative | 17 (54.8) | 116 (76.8) | 6.317 | 0.012 |
COPD[n(%)] | ||||
Positive | 0 (0) | 11 (7.3) | ||
Negative | 31 (100) | 140 (92.7) | 1.292 | 0.256 |
History of upper abdominal surgery [n(%)] | ||||
Positive | 13 (41.9) | 26 (17.2) | ||
Negative | 18 (58.1) | 125 (82.8) | 9.333 | 0.002 |
Diameter of common bile duct [mm,n(%)] | ||||
≥ 15 | 23 (74.2) | 61 (40.4) | ||
< 15 | 8 (25.8) | 90 (59.6) | 11.821 | 0.001 |
Postoperative blood loss > 300 ml [n(%)] | ||||
Positive | 5 (16.1) | 23 (15.2) | ||
Negative | 26 (83.9) | 128 (84.8) | < 0.001 | > 0.999 |
Postoperative bile leakage [n(%)] | ||||
Positive | 3 (9.7) | 13 (8.6) | ||
Negative | 28 (90.3) | 138 (91.4) | < 0.001 | > 0.999 |
Pancreatitis [n(%)] | ||||
Positive | 3 (9.7) | 17 (11.3) | ||
Negative | 28 (90.3) | 134 (88.7) | < 0.001 | > 0.999 |
Complication [n(%)] | ||||
Positive | 6 (19.4) | 30 (19.9) | ||
Negative | 25 (80.6) | 121 (80.1) | 0.004 | 0.948 |
Bile duct sediment-like stones [n(%)] | ||||
Positive | 26 (83.9) | 37 (24.5) | ||
Negative | 5 (16.1) | 114 (75.5) | 40.052 | < 0.001 |
Pinaverium bromide (Oral administration) [n(%)] | ||||
Positive | 7 (22.6) | 78 (51.7) | ||
Negative | 24 (77.4) | 73 (48.3) | 8.735 | 0.003 |
Operation [n(%)] | ||||
Backtracking full-thickness continuous everting (BFCE) suture | 9 (29) | 81 (53.6) | ||
T-tube drainage | 22 (71) | 70 (46.4) | 6.232 | 0.013 |